Dogwood Therapeutics Statistics
Total Valuation
DWTX has a market cap or net worth of $5.60 million. The enterprise value is $4.34 million.
Important Dates
The next estimated earnings date is Tuesday, March 11, 2025, before market open.
| Earnings Date | Mar 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DWTX has 1.33 million shares outstanding. The number of shares has increased by 20.17% in one year.
| Current Share Class | 1.33M |
| Shares Outstanding | 1.33M |
| Shares Change (YoY) | +20.17% |
| Shares Change (QoQ) | +21.21% |
| Owned by Insiders (%) | 5.62% |
| Owned by Institutions (%) | 2.94% |
| Float | 1.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.60 |
| P/TBV Ratio | 6.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.71
| Current Ratio | 1.71 |
| Quick Ratio | 1.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -200.48% and return on invested capital (ROIC) is -127.45%.
| Return on Equity (ROE) | -200.48% |
| Return on Assets (ROA) | -96.64% |
| Return on Invested Capital (ROIC) | -127.45% |
| Return on Capital Employed (ROCE) | -613.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.43M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.25% in the last 52 weeks. The beta is 1.94, so DWTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.94 |
| 52-Week Price Change | -50.25% |
| 50-Day Moving Average | 6.04 |
| 200-Day Moving Average | 5.08 |
| Relative Strength Index (RSI) | 37.07 |
| Average Volume (20 Days) | 162,272 |
Short Selling Information
The latest short interest is 38,193, so 2.87% of the outstanding shares have been sold short.
| Short Interest | 38,193 |
| Short Previous Month | 87,277 |
| Short % of Shares Out | 2.87% |
| Short % of Float | 3.06% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.82M |
| Pretax Income | n/a |
| Net Income | -5.73M |
| EBITDA | n/a |
| EBIT | -5.82M |
| Earnings Per Share (EPS) | -$6.42 |
Full Income StatementBalance Sheet
The company has $2.04 million in cash and n/a in debt, giving a net cash position of $2.04 million or $1.53 per share.
| Cash & Cash Equivalents | 2.04M |
| Total Debt | n/a |
| Net Cash | 2.04M |
| Net Cash Per Share | $1.53 |
| Equity (Book Value) | 949,431 |
| Book Value Per Share | 0.86 |
| Working Capital | 949,431 |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.13M |
| FCF Per Share | -$3.10 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |